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DC-SIGN-Mediated Internalization of HIV
Is Required for Trans-Enhancement
of T Cell Infection
the chemokine receptor CCR5 (R5 strains) have been
found to be preferentially transmitted following initial
exposure to virus (Cornelissen et al., 1995; Huang et
al., 1996; Samson et al., 1996; van’t Wout et al., 1994).
Viruses that use the chemokine receptor CXCR4 (X4
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strains) often prevail during progression to immunodefi-New York University School of Medicine
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Although the mechanism of HIV entry has been stud-3 Howard Hughes Medical Institute
ied extensively in cultured cells, the factors that contrib-Department of Biochemistry and Molecular Biophysics
ute to infection in vivo remain poorly understood. It hasCollege of Physicians and Surgeons
been proposed that dendritic cells (DC), which are prev-Columbia University
alent at mucosal surfaces and function as antigen-New York, New York 10032
presenting cells in draining lymphatic tissues, have an
important role in HIV infection (reviewed in Rowland-
Jones, 1999; Steinman et al., 1999). These cells haveSummary
been shown to facilitate infection with HIV when they
are cocultured with T cells (Cameron et al., 1992; PopeFusion of the human immunodeficiency virus (HIV) to
et al., 1995). HIV replicates poorly in immature DC inthe plasma membrane of target cells is mediated by
vitro (Cameron et al., 1992; Granelli-Piperno et al., 1999),interaction of its envelope glycoprotein, gp120, with
and it has been difficult to study infection of DC in vivo.CD4 and appropriate chemokine receptors. gp120 ad-
A novel function for DC was proposed after it was foundditionally binds to DC-SIGN, a C-type lectin expressed
that HIV binds to DC-SIGN, a cell surface C-type lectinon immature dendritic cells. This interaction does not
on these cells (Geijtenbeek et al., 2000a). DC-SIGN hadresult in viral fusion, but instead contributes to en-
been previously identified as a gp120 binding proteinhanced infection in trans of target cells that express
(Curtis et al., 1992) and was subsequently isolated fromCD4 and chemokine receptors. Here we show that
monocyte-derived DC as a binding partner for ICAM-3DC-SIGN mediates rapid internalization of intact HIV
(Geijtenbeek et al., 2000b). We showed that, in contrastinto a low pH nonlysosomal compartment. Internalized
to CD4 and chemokine receptors, DC-SIGN does notvirus retains competence to infect target cells. Re-
mediate the entry of HIV bound to it. However, DC-moval of the DC-SIGN cytoplasmic tail reduced viral
SIGN-expressing cells pulsed with HIV transmit virus touptake and abrogated the trans-enhancement of T cell
appropriate target cells and retain infectious particlesinfection. We propose that HIV binds to DC-SIGN to
for several days in culture. In addition, at low viral multi-gain access to an intracellular compartment that
plicity of infection (MOI), activated T lymphocytes cocul-contributes to augmentation or retention of viral in-
tivated with DC-SIGN-expressing cells are much morefectivity.
readily infected than lymphocytes exposed to control
cells. Similar results were observed with several labora-Introduction
tory-adapted and primary R5 strains of HIV. Because
DC-SIGN is expressed at high levels on immature den-The human immunodeficiency virus (HIV) infects cells
dritic cells, we proposed that it may have an importantthat express CD4 and a variety of chemokine receptors,
role in DC-mediated transport of virus from mucosal
particularly CCR5, at their surface (reviewed in Simmons
sites to secondary lymphoid tissues, where it could effi-
et al., 2000). Infection is initiated by binding of the sur-
ciently transfer virus to T cells (Geijtenbeek et al., 2000a).
face subunit of envelope glycoprotein (Env), gp120, to Dendritic cells are specialized sentinel cells that take
CD4 on the target cell. This interaction results in a con- up antigen, process it, and present it to T lymphocytes
formational change in gp120 that allows it to bind to a following migration to lymphoid organs (reviewed in
member of the family of seven transmembrane domain Banchereau et al., 2000; Thery and Amigorena, 2001).
G protein-coupled chemokine receptors (Lapham et al., Because antigens are engulfed and digested by DC, it
1996; Trkola et al., 1996; Wu et al., 1996). Interaction is puzzling that HIV infectivity increases and even per-
with the chemokine receptor releases the fusogenic po- sists for days after virions bind to the surface of these
tential of the transmembrane subunit of Env, gp41, cells. Electron micrographic examination of HIV-exposed
whose N-terminal fusion peptide is inserted into the DC has shown the presence of intact viral particles in
target cell lipid bilayer, initiating fusion of the viral and intracellular vesicular compartments (Hladik et al., 1999).
host membranes. These contacts between envelope Because DC-SIGN has putative tyrosine and dileucine
glycoprotein and CD4 plus chemokine receptors are internalization motifs in its cytoplasmic tail, we reasoned
believed to be sufficient for viral entry. Isolated strains that HIV particles may undergo endocytosis after bind-
of HIV utilize distinct chemokine receptors for infection ing to the cell surface lectin. In the current study, we have
(Alkhatib et al., 1996; Choe et al., 1996; Deng et al., 1996; examined the role of HIV endocytosis in the process of
Dragic et al., 1996; Feng et al., 1996). Those that use DC-SIGN-mediated augmentation of viral infectivity. We
show that HIVs of variable tropism, but not murine re-
troviruses, are captured and display enhanced infectiv-4 Correspondence: littman@saturn.med.nyu.edu
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ity following interaction with cells that express DC-SIGN. cle that encoded the Renilla luciferase reporter gene
with the glycosylated ecotropic Moloney murine leuke-Following binding to DC-SIGN, HIV is internalized into
a low pH nonlysosomal compartment, which allows re- mia virus (MLV) envelope glycoprotein. The MLV Renilla
luciferase-pseudotyped virus was mixed with HIV fireflytention of infectivity. The DC-SIGN-mediated internal-
ization enhances the amount of virus captured by cells, luciferase particles pseudotyped with the R5 tropic en-
velope JRFL. The virus particles encoding two differentand truncation of the cytoplasmic domain of DC-SIGN
results in decreased viral uptake and loss of enhance- forms of luciferase allowed us to simultaneously quanti-
tate infectivity of each particle within the same culture.ment of infectivity. Together, these findings suggest that
HIV has evolved to exploit the cellular machinery and The viruses were mixed to give comparable levels of
infection of murine 3T3 targets cells expressing humanthe physiological functions of dendritic cells to its ad-
vantage for optimizing transmissibility between indi- CD4, CCR5, and Cyclin T1 (Figure 1E). Human cyclin T1
is required for efficient transcription of LTR-driven HIVviduals.
genes in murine cells. When this same mixture was
added to human 293T targets expressing the necessaryResults
HIV entry receptors, only the HIV JRFL firefly luciferase
virus could infect, thus verifying that the Renilla lucifer-DC-SIGN Binds Numerous HIV and SIV Strains
ase virus was in fact pseudotyped with the ecotropicbut Not MLV-Pseudotyped Virus
MLV envelope. THP or THP DC-SIGN cells were incu-To examine the specificity of the interaction between
bated with this mixture of virus, washed, and then addedDC-SIGN and viral envelope glycoproteins, a human
to 3T3 target cells (Figure 1F). Only the virus pseu-monocytic cell line, THP, was transduced with a retrovi-
dotyped with the HIV envelope could be captured andrus encoding the cDNA for DC-SIGN. This THP DC-
transferred to the 3T3 target cells. Together, these dataSIGN cell does not express CD4 or CCR5 and cannot
demonstrate that although DC-SIGN can capture andbe infected by HIV (data not shown). Binding of purified
enhance a wide variety of HIV and SIV strains, this broadfluorescently labeled envelope glycoproteins to these
specificity among primate lentiviruses does not extendcells demonstrated that DC-SIGN could interact with
to other retroviruses containing glycosylated envelopes.gp120 from HIV strains with R5, X4, and R5X4 tropism
and with envelope glycoprotein from simian immunode-
ficiency virus (SIV) (Figure 1A). This was consistent with HIV Is Internalized into a Low pH Endosomal
Compartment following Binding to DC-SIGNassays in which binding of HIV particles was measured
by utilizing a replication defective HIV-1 encoding the The cytoplasmic tail of DC-SIGN contains two classically
defined putative internalization motifs, a dileucine-basedfirefly luciferase reporter gene (Figure 1B). Expression
of the reporter provides a quantitative measure of a motif and a tyrosine-based motif (Mellman, 1996; Trow-
bridge et al., 1993). This observation led to the questionsingle round of HIV infection. THP DC-SIGN cells were
pulsed with HIV-luciferase pseudotyped with envelope of whether virus remains on the cell surface or is internal-
ized following interaction with DC-SIGN. To answer thisglycoproteins from primary or laboratory-adapted R5,
X4, and R5X4 HIV strains or from SIV. The cells were question, we incubated THP DC-SIGN cells on ice with
purified gp120 that was directly conjugated to the fluo-then washed extensively and added to HIV-permissive
293T target cells expressing human CD4, CXCR4, and rescent marker FITC (Figure 2A); the integrity of the
gp120 was confirmed by binding to THP cells expressingCCR5. Cells were harvested 48 hr later and assayed for
luciferase activity. DC-SIGN was able to capture and CD4 (data not shown). After washing, cells were shifted
to 37C for the times indicated. They were then treatedtransmit all virus strains tested; thus, DC-SIGN is capa-
ble of binding to a broad range of primate lentiviruses. with trypsin or mock treated and then stained for re-
maining surface expression of DC-SIGN as a control forDC-SIGN was previously shown to enhance HIV infec-
tion of T cells at low virus titer (Geijtenbeek et al., 2000a). proteolysis. Without shifting to 37C, trypsin treatment
resulted in the loss of both gp120-FITC and surface DC-To test the specificity of this enhancement, we used HIV-
luciferase pseudotyped with Env from multiple strains of SIGN. After incubation for 10 min at 37C, however, a
portion of the gp120-FITC signal was protected fromHIV and SIV to infect T cells. When low amounts of virus
were used, infection was greatly enhanced by coculture proteolysis despite complete loss of surface DC-SIGN
expression following treatment. THP DC-SIGN cells thatwith THP DC-SIGN cells when compared to the same
amount of virus added to a coculture with the parental were first fixed with paraformaldehyde or that were con-
tinually maintained on ice did not show gp120-FITC pro-cell line or T cells alone (Figure 1C). Enhancement was
obtained with all HIV and SIV strains tested and also tease protection (Figure 2B, and data not shown). A time
course showed that DC-SIGN mediated rapid internaliza-with replication-competent virus when activated T cells
were cocultured with THP DC-SIGN cells or human DC tion of HIV envelope (Figure 2B).
Following internalization by DC-SIGN, the intensity of(Figure 1D, and data not shown). Enhancement with
replication-competent virus was not observed upon co- the gp120-FITC signal was found to increase with time
(Figures 2C and 2D). Since the fluorescence of FITC hasculture with THP cells or DC pretreated with an anti-
DC-SIGN antibody. been reported to be pH sensitive (Geisow, 1984), we
sought to determine if the increase in gp120-FITC fluo-Because all primate lentiviruses that we tested dis-
played interaction with DC-SIGN, we wished to deter- rescence intensity was due to internalization into a low
pH compartment. When the intracellular pH of THP DC-mine whether other retroviruses containing glycosylated
envelope protein could similarly bind to DC-SIGN. We SIGN cells was neutralized by pretreatment of cells with
weak bases such as NH4Cl or chloroquine, the increasetherefore pseudotyped an envelope-deficient HIV parti-
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Figure 1. Interaction of Primate Lentivirus
but Not MLV Envelope Glycoproteins with
DC-SIGN
(A) Binding of recombinant envelope from
several strains of HIV and SIV to DC-SIGN.
THP or THP DC-SIGN cells were incubated
with purified HIV gp120 or SIV gp140 and sub-
sequently stained with pooled human anti-
HIV serum or monkey anti-SIV serum, and
a fluorescently labeled secondary antibody.
Cells were then washed and analyzed for en-
velope binding by FACS. LAI, IIIB, MN, and
CM are CXCR4 tropic envelopes, while JRFL
and Clade E are CCR5 tropic envelopes.
(B) DC-SIGN can capture R5, X4, and R5X4
strains of HIV and SIV. THP or THP DC-SIGN
cells were pulsed with pseudotyped virus en-
coding luciferase at high multiplicity of infec-
tion, washed, and then added to 293T cells
expressing the HIV entry receptors CD4,
CCR5, and CXCR4. Infection was assayed 2
days later by measuring luciferase activity in
the 293T cells. JRFL and 93TH966.8 are R5
strains; HxB2, 92HT599.24, and 92UG012.16
are X4 strains; 89.6 is an R5X4 strain.
(C) DC-SIGN can enhance infection with R5,
X4, and R5X4 strains of HIV and SIV at low
virus multiplicity of infection. HIV-luciferase-
pseudotyped virus was incubated with THP
cells, THP DC-SIGN cells, or in medium alone
for 2 hr at 37C. Activated T cells were then
added and infection was assayed 2 days later.
(D) DC-SIGN expressed on dendritic cells is
required for enhancement of infection with
replication-competent HIV. Monocyte-derived
DC were incubated with replication-compe-
tent HIV-1 LAI and then added to activated
T cells. For antibody blocking experiments,
DC were preincubated with anti-DC-SIGN an-
tibody (25 g/ml) for 1 hr prior to addition of
virus. Aliquots of the coculture supernatants
were taken at the indicated time points and
assayed for HIV p24 antigen by ELISA.
(E and F) DC-SIGN cannot bind HIV pseu-
dotyped with MLV envelope glycoprotein. HIV
expressing the reporter Renilla luciferase was
pseudotyped with the MLV envelope and
mixed with HIV firefly luciferase pseudotyped
with the HIV envelope JRFL. The viral mixture
was used to directly infect murine 3T3 cells
expressing human CD4, CCR5, and cyclin T1
or 293T-CD4-CCR5 cells (E) or to infect 3T3
cells following capture with THP or THP DC-
SIGN cells (F).
in gp120-FITC fluorescence intensity was abolished, (Hopkins, 1983; Hopkins and Trowbridge, 1983; Ya-
mashiro et al., 1984). After binding on ice, the cells wereeven though the kinetics of internalization, as judged
by protease protection, was unchanged from untreated shifted to 37C for various times and then fixed and
permeabilized so that they could be stained for the latecells (Figures 2C and 2D, and data not shown). This
suggests that internalization by DC-SIGN results in entry endosomal/lysosomal marker LAMP (Chen et al., 1988).
Without the shift to 37C, both transferrin and HIV wereinto a low pH compartment.
To verify that DC-SIGN could mediate internalization at the cell surface (Figure 3A). After a short incubation
of 5–15 min at 37C, most of the HIV fluorescence wasof whole virus particles in addition to gp120, we exam-
ined HIV-pulsed human dendritic cells by fluorescence colocalized with transferrin in intracellular nonlysosomal
compartments. After 45 min, however, much of the HIVconfocal microscopy. The cells were pulsed with HIV
particles on ice and then fluorescently labeled with an was segregated from transferrin and localized in a dis-
tinct compartment that is nonlysosomal, as evidencedanti-HIV serum. The cells were simultaneously pulsed
with fluorescently labeled transferrin, which is selec- by the failure to colocalize with LAMP. Even after a 2 hr
incubation at 37C, the HIV did not enter LAMP-positivetively internalized by the transferrin receptor into early
endosomal and perinuclear recycling compartments compartments (data not shown). THP DC-SIGN cells
Immunity
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Figure 2. HIV gp120 Is Internalized by DC-
SIGN into a Low pH Compartment
(A) Binding to DC-SIGN results in protection
of gp120-FITC from trypsin treatment. THP
DC-SIGN cells were stained with gp120-FITC
on ice, washed, and then shifted to 37C for
the times indicated. Cells were then treated
with trypsin or mock treated, fixed, and
stained with an anti-DC-SIGN antibody and
a PE-labeled secondary antibody for the re-
maining surface expression of DC-SIGN to
verify proteolysis. Cells were then washed
thoroughly and analyzed by FACS.
(B) Kinetic analysis of gp120-FITC proteolysis
protection. THP DC-SIGN cells were treated
as above or were first fixed with 2% paraform-
aldehyde to assay for gp120-FITC internaliza-
tion. The percent gp120-FITC protection was
calculated by determining the ratio of %
FITC-positive cells with trypsin treatment
versus % FITC-positive cells upon mock
treatment.
(C and D) pH-dependent change in fluores-
cence of internalized gp120-FITC. gp120-
FITC was bound to THP DC-SIGN cells on
ice. After washing, the cells were incubated
at 37C for the times indicated in the presence
or absence of NH4Cl to neutralize intracellular pH. Cells were then proteolyzed to remove surface gp120-FITC and analyzed by FACS. FACS
profile (C) and kinetic analysis (D) of change in gp120-FITC fluorescence following shift to 37C are shown.
were also found to internalize HIV with similar kinetics protected from protease, whereas the HIV-Renilla lucif-
erase bound to the THP DC-SIGN 35 cells was elimi-(data not shown).
nated (Figure 3C). These results indicate that even after
internalization of HIV by DC-SIGN, infectivity is pre-Internalized HIV Remains Competent for Infection
served and internalized virus remains competent forof a Second Target Cell
transmission to a second target cell.We next sought to confirm that internalized virus was
still infectious and could be transferred to a second
Soluble DC-SIGN Does Not Mediate Enhancementinfectable target cell. We therefore pulsed either THP
of InfectionDC-SIGN cells or DC on ice with replication-defective
Contact with DC-SIGN alone may be sufficient to medi-HIV-luciferase pseudotyped with the HIV JRFL envelope
ate conformational changes in envelope glycoproteinglycoprotein (Figure 3B). We then incubated the cells
that result in enhanced HIV infection. Alternatively, therefor the indicated times at 37C, returned them to ice,
may be requirements that necessitate that DC-SIGN beand pulsed them with an HIV JRFL-pseudotyped virus
expressed on a cell. To test the former possibility, weexpressing the reporter GFP. The cells were then treated
generated a soluble form of DC-SIGN (sDC-SIGN) bywith trypsin or mock treated, washed, and mixed with
expressing and purifying the entire extracellular domain293T target cells expressing human CD4 and CCR5.
of the protein. The sDC-SIGN blocked capture of virusWithout the incubation at 37C, both the HIV-luciferase
by THP DC-SIGN cells (Figure 4A), but did not enhance
virus and the HIV-GFP virus were sensitive to proteoly-
infectivity when mixed with virus and target cells (Figure
sis. After incubation for 20 min at 37C, however, the 4B). This suggests that the interaction between enve-
HIV-luciferase virus was protected from proteolysis and lope glycoprotein and DC-SIGN alone is not sufficient
could be transmitted to the target cell, while the HIV- for enhancement of HIV infection of T cells, and it is
GFP remained protease sensitive, thus verifying that consistent with the notion that DC-SIGN must be ex-
the trypsin treatment was effective. A time course of pressed on a cell to enhance viral entry.
protease protection was also performed (Figure 3C).
THP DC-SIGN cells were incubated on ice with an HIV DC-SIGN Internalization Results in Increased Viral
reporter virus expressing firefly luciferase. THP cells ex- Capture and Is Necessary for Trans-Enhancement
pressing a truncated form of DC-SIGN (35) lacking the of HIV Infection
cytoplasmic internalization motifs were incubated on To determine whether DC-SIGN-mediated internaliza-
ice with HIV expressing the reporter Renilla luciferase. tion is required for enhancement of HIV infection, we
Following incubation with virus, both cell lines were generated THP cells expressing mutant forms of DC-
washed thoroughly to remove unbound virus and the SIGN in which the cytoplasmic domain of the molecule
THP DC-SIGN and THP DC-SIGN 35 cells were mixed. was either partially (20) or fully (35) truncated. The
The cells were then incubated at 37C for the indicated partial truncation removed the 20 amino acids from the
times and mock treated or protease treated, and then N terminus that include the putative dileucine-based
added to infectable 293T target cells. After incubation internalization motif, while the full truncation removed
35 amino acids that include both the dileucine motif andat 37C, the HIV bound to the THP DC-SIGN cells was
DC-SIGN-Mediated Internalization of HIV
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Figure 3. DC-SIGN-Mediated HIV Internal-
ization and Its Effect on Viral Infectivity
(A) Colocalization of internalized HIV with
transferrin receptor. Monocyte-derived DC
were incubated on ice with Cy3-labeled inacti-
vated HIV and Alexa 633-conjugated trans-
ferrin. After incubation at 37C for the indicated
times, the cells were stained intracellularly
with an anti-LAMP antibody conjugated to
FITC. Cells were visualized using confocal mi-
croscopy. Alexa 633 and FITC color assign-
ment were exchanged to allow better visual-
ization.
(B and C) Internalized HIV remains competent
for infection of a second target cell. (B) HIV-
luciferase (JRFL) was incubated with THP
DC-SIGN cells or DC on ice. Cells were then
washed and shifted to 37C for the times indi-
cated, placed back on ice, and incubated with
a second pseudotyped virus, HIV-GFP (JRFL).
The cells were then treated with trypsin or
mock treated and added to 293T-CD4-CCR5
target cells. HIV infection was determined by
measuring luciferase activity with a lumino-
meter or GFP expression by FACS. (C) THP
cells expressing wild-type or a truncated form
of DC-SIGN (35) were incubated on ice with
pseudotyped particles encoding firefly lucif-
erase or Renilla luciferase, respectively. The
cells were then washed, mixed, and incu-
bated at 37C for the indicated times. They
were then mock treated or treated with prote-
ase, and mixed with 293T-CD4-CCR5 target
cells. Infection was read out 2 days later by
measuring firefly and Renilla luciferase sig-
nals in cell lysates.
the tyrosine-based motif. THP cells transduced with the ever, showed little increase when incubation was carried
out at 37C. The THP DC-SIGN Hi cell line captured moremutant and wild-type (wt) DC-SIGN were sorted by flow
cytometry to obtain comparable levels of expression virus under both conditions relative to the wild-type cell
line with lower expression. This suggests that internal-(Figure 5A). THP DC-SIGN wt cells were also sorted for
high expression. ization is a mechanism by which DC-SIGN-expressing
cells increase viral capture, which was also confirmedThese cells were used in capture experiments with
incubations performed on ice to block internalization by incubating THP DC-SIGN cells with virus, washing,
and then lysing the cells and directly measuring theand receptor recycling. When cells were pulsed with
virus at high MOI, washed extensively with cold buffer, captured p24 HIV antigen by ELISA (Figure 5C). We also
found that gp120 internalization by THP cells expressingand then added to target cells, the mutant and wild-
type cells showed approximately equal levels of viral cytoplasmic truncated DC-SIGN was significantly im-
paired (data not shown). Despite being able to bindcapture and transmission (Figure 5B). This was ex-
pected since the extracellular domain of DC-SIGN was to gp120 with high affinity, THP cells expressing CD4
captured only modest amounts of virus (Figure 5B, andintact on all cells, and at high virus doses, a sufficient
number of particles would likely be retained on the sur- data not shown).
Although THP cells expressing DC-SIGN with cyto-face and could then be transmitted to infectable target
cells. When incubation with virus was performed at 37C, plasmic domain truncations could capture virus, they
failed to mediate enhancement of T cell infection at lowcells expressing wild-type DC-SIGN showed a signifi-
cant increase in captured infectious virus. Cells express- multiplicity of infection (Figure 5D). Even when the wild-
type THP DC-SIGN cells were incubated with 5-fold lessing DC-SIGN with deleted internalization motifs, how-
Immunity
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Figure 4. Soluble DC-SIGN Does Not En-
hance HIV Infection
(A) sDC-SIGN inhibits capture of HIV by THP-
DC-SIGN cells. sDC-SIGN was preincubated
with HIV for 30 min before mixing with THP
DC-SIGN cells in a capture assay.
(B) Absence of sDC-SIGN enhancement of
HIV infection of T cells. Pseudotyped HIV was
incubated at 37C at low MOI with THP DC-
SIGN cells or sDC-SIGN alone at the concen-
trations indicated for 2 hr and then added to
activated T cells.
virus, the enhancement of target T cell infection was of HIV into a low pH compartment might be important.
We therefore used concanamycin A, a specific inhibitorconsiderably greater than with cell lines expressing trun-
cated DC-SIGN (data not shown). Thus, internalization of vacuolar proton pumps, to neutralize intracellular pH.
THP DC-SIGN cells that were pretreated with concana-appears to be critical for mediating trans-enhancement
of HIV infection. mycin A for 2 hr and for an additional 2 hr during incuba-
tion with HIV at high MOI were still able to capture and
transmit virus to target cells after washing to remove freeNeutralization of Intracellular pH Results in Loss
of DC-SIGN-Mediated Trans-Enhancement viral particles (Figure 6A). In contrast, concanamycin A
treatment completely abolished the ability of THP DC-of HIV Infection
Since HIV internalization appears to be critical for en- SIGN cells to enhance viral infection of T cells at low
viral titer (Figure 6B). Similar results were obtained whenhancement of infection, we surmised that internalization
Figure 5. Mutant DC-SIGN Molecules that
Lack the Cytoplasmic Domain Have Reduced
HIV Internalization and Are Deficient for En-
hancement of HIV Infection
(A) FACS analysis of THP cells transduced
with wild-type or mutant DC-SIGN molecules
lacking the first 20 aa (20) or 35 aa (35) of
the cytoplasmic domain.
(B) Reduced capture of HIV at 37C by cells
expressing truncated DC-SIGN. THP cells ex-
pressing wt or mutant forms of DC-SIGN were
incubated with HIV-luciferase (JRFL) on ice
or at 37C. The cells were then washed exten-
sively and mixed with 293T-CD4-CCR5 target
cells and luciferase activity was measured 2
days later.
(C) Reduced HIV particle binding to truncated
DC-SIGN at 37C. THP cells expressing wt
or mutant forms of DC-SIGN were incubated
with HIV-luciferase (JRFL) on ice or at 37C.
The cells were then washed extensively,
lysed, and assayed for HIV p24 antigen by
ELISA.
(D) Requirement for DC-SIGN cytoplasmic
domain in trans-enhancement of infection.
Wild-type or mutant THP DC-SIGN cells were
incubated with pseudotyped HIV-luciferase
(JRFL) at 37C at low virus concentration and
then added to activated T cell targets.
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compartments has been shown to result in rapid loss
of viral infectivity (Kempf et al., 1991). Exposure to the
moderate pH of early endosomal/recycling compart-
ments, however, does not significantly reduce viral in-
fectivity (data not shown).
Internalization appears to be critical for the enhance-
ment of viral infectivity since mutant DC-SIGN molecules
that lack internalization signals can no longer enhance.
However, cells expressing the cytoplasmic truncated
forms of DC-SIGN are still capable of binding and trans-
mitting virus to a second target cell at high viral MOI.
This suggests that the observed enhancement is notFigure 6. Neutralization of Intracellular pH Results in Loss of DC-
simply due to effective increases in the local concentra-SIGN-Mediated Infection Enhancement
tion of virus due to adsorption of virus on DC-SIGN-(A) Capture of HIV after treatment with concanamycin A. THP DC-
expressing cells. In addition, the observation that neitherSIGN cells were pretreated with 10 nM concanamycin A for 2 hr or
mock treated, and then pulsed with HIV-luciferase (JRFL) at high soluble DC-SIGN nor the THP DC-SIGN 35 mutant can
MOI for 2 hr in the continued presence of drug. Cells were then mediate infection enhancement argues that contact be-
washed extensively and treated cells were resuspended in medium- tween DC-SIGN and HIV alone is unlikely to result in
containing drug. Concanamycin was diluted out upon addition to changes (e.g., conformational) in viral proteins that lead
293T-CD4-CCR5 cells. Luciferase was measured 2 days later.
to increased infectivity or stability.(B) Abrogation of trans-enhancement of HIV infection by treatment
Intracellular pH appears to be critical for DC-SIGN-with concanamycin A. THP DC-SIGN cells were pretreated with 10
mediated enhancement since treatment of DC-SIGN ex-nM concanamycin A for 2 hr before the addition of HIV-luciferase
(JRFL) at low MOI. After 2 additional hr, cell/virus was added to pressing cells with lysosomotropic agents results in a
activated T cells in a large volume to dilute the concanamycin, and loss of trans-enhancement. HIV is known to rapidly lose
infection was read 2 days later. infectivity at 37C, and we have shown that HIV bound
to THP DC-SIGN cells can retain the infectivity of virus
for several days (Geijtenbeek et al., 2000a). Virus boundintracellular pH was neutralized by the weak bases
to THP cells expressing a cytoplasmic truncated formNH4Cl or chloroquine (data not shown). of DC-SIGN, however, cannot retain viral infectivity (data
not shown). Therefore, it may be that internalization intoDiscussion
a mildly acidic compartment results in stabilization of
virus. It has been reported that follicular dendritic cellsWe have described a novel mechanism by which DC-
(FDC) can protect immune complexes from degradationSIGN mediates internalization of HIV particles into a
and retain antigen in native conformation for severalnonlysosomal intracellular compartment that appears
months (Mandel et al., 1980; Tew et al., 1980). In addition,to be critical for DC-SIGN enhancement of HIV infection.
FDC have recently been described to retain infectious
This activity occurs with a broad range of primate lentivi-
HIV (Smith et al., 2001). This was demonstrated by in-
ruses. Previous studies have proposed that DC may be
jecting mice with HIV in the footpad and recovering
responsible for the preferential transmission of R5 tropic
infectious virus 9 months later in draining lymph nodes.
viruses following initial exposure of the host. The obser-
Since HIV cannot replicate in the mouse, it suggests
vation that infection by R5, X4, and R5X4 viruses can that the infectivity of the original virus was maintained.
all be enhanced by DC-SIGN suggests that this molecule The retention of HIV infectivity by FDC may involve inter-
is not responsible for the observed bottleneck in trans- nalization (Tacchetti et al., 1997). One possibility is that
mission. Although DC-SIGN shows broad specificity HIV is internalized by immature DC into an intracellular
among primate lentiviruses, it cannot bind to HIV parti- compartment that has similar functions, such as main-
cles pseudotyped with the retroviral ecotropic MLV en- taining the native conformation of HIV envelope glyco-
velope. The inability to bind to MLV may be due to the protein and protecting the virus from degradation. Pres-
reduced level of MLV gp70 glycosylation compared to ervation of viral infectivity may require low pH exposure,
that of HIV gp120, different orientation of the sugars, or although this alone does not appear to be sufficient for
lack of amino acid sequences that may contribute to enhanced infectivity (data not shown). Other enveloped
specificity. Overall, however, it suggests that primate animal viruses such as influenza and Semliki Forest virus
lentiviruses have uniquely adapted to coopt DC-SIGN have been demonstrated to have pH-induced changes
on dendritic cells. that significantly increase viral stability (Bullough et al.,
Following the interaction of HIV with DC-SIGN, the 1994; Fuller et al., 1995; Hernandez et al., 1996; Ruigrok
virus is rapidly internalized. Virions remain infectious et al., 1988). Although low pH exposure is not required
even after internalization into a low pH compartment. for HIV infection, it is possible that such exposure in
Previous studies have demonstrated that even early en- an intracellular compartment within the DC results in
dosomal/recycling compartments are mildly acidic, with conformational changes that preserve or increase the
a pH estimated to be between 6.0 and 6.8 (reviewed in infectivity of virus. It has been reported that low pH
Mellman, 1996). The pH of late endosomal/lysosomal exposure may prime gp41 for fusion (Fackler and Pe-
compartments is significantly lower at 5.0–5.5. The vast terlin, 2000). This is consistent with the observation that
majority of internalized HIV does not enter late endoso- use of lysosomotropic agents that neutralize intracellu-
mal or lysosomal compartments, as demonstrated by lar pH abrogate DC-SIGN-mediated enhancement of
the failure to colocalize with LAMP, even at late time T cell infection.
We propose a model in which DC located at mucosalpoints. Additionally, the low pH of these degradative
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harvested 48 hr posttransfection, filtered, and frozen in aliquotssites bind and internalize intact HIV particles, which can
at 120C. Virus was titered by infecting 293T-CD4-CCR5 cells andthen be transported to secondary lymphoid tissue by
measuring luciferase activity in cell lysates 48 hr postinfection usingmigrating DC. This internalization increases the amount
a luciferase reporter assay kit (Promega, Madison, WI). Low titer
of virus that can be retained by DC-SIGN-expressing infections were performed with virus dilutions that were at the low
cells, which may be critical in vivo since it would be limit of detection in purified activated T cell targets. High titer infec-
tions utilized virus at concentrations 10- to 100-fold higher.expected to lead to a commensurate increase in the
amount of virus that can be transported by DC from
gp120 Binding Assayperipheral mucosal sites, where virus amounts are likely
THP DC-SIGN cells were incubated on ice with 50 nM of purifiedto be low, to secondary lymphoid tissue. Internalization
HIV gp120 or SIV gp140 (obtained from the NIH AIDS Research andmay also result in changes in the viral particles that are
Reference Reagent Program) for 1 hr in staining buffer (phosphate
dependent upon low pH exposure and that may result buffered saline [PBS] with 2% FCS, 1 mM CaCl2, and 1 mM MgCl2).
in the retention and/or augmentation of viral infectivity. All subsequent washes and antibody dilutions were performed with
Although internalization of HIV may be important for cold staining buffer. Cells were washed and incubated with pooled
serum from HIV-positive patients (for gp120 stains; a kind gift of J.the observed increase in viral infectivity, several impor-
Moore) or monkey anti-SIV serum (for gp140 stains; a kind gift oftant questions remain. It is still unclear whether HIV
J. Moore) on ice, washed, and labeled with goat anti-human IgGvirions continue to associate with DC-SIGN after inter-
secondary antibody conjugated to phycoerythrin (PE) (R&D Sys-
nalization and whether DC-SIGN mediates the return of tems). After a final wash, cells were analyzed by FACS.
virus to the surface. Since DC-SIGN-mediated enhance-
ment of infection is observed with nonreplication-com- DC-SIGN Capture, Particle Binding, and Infection Enhancement
petent pseudotyped virus, it is unlikely that the viral Capture and enhancement of infection by DC-SIGN-expressing cells
has been described previously (Geijtenbeek et al., 2000a). Briefly,membrane fuses with the DC-SIGN-expressing cell
5  104 THP or THP DC-SIGN cells were incubated with HIV for 2membrane. This means that the virus must recycle back
hr at 37C or on ice as indicated. For capture experiments, cellsto the surface so that it can contact entry receptors on
were washed thoroughly in medium and then added to an equal
the target cell. Whether this recycling of virus is constitu- number of 293T cells expressing CD4 and CCR5 or 3T3 cells ex-
tive or regulated remains to be determined. The exact pressing CD4, CCR5, and human Cyclin T1 in a 24-well plate. To
nature of the changes that occur upon internalization assay HIV particle binding by DC-SIGN, THP or THP DC-SIGN cells
were incubated with HIV for 2 hr at 37C or on ice. Cells were thenis also unclear. Internalization may function simply to
washed thoroughly, pelleted, lysed, and assayed for HIV p24 antigenconcentrate virus for more efficient transfer to the target,
by ELISA (Coulter, Miami, FL). Enhancement experiments were per-or the virus may undergo covalent modifications or con-
formed by incubating 5  104 THP, THP DC-SIGN cells, or DC with
formational changes that result in higher viral fusogeni- HIV for 2 hr at 37C. HIV/cells were then directly added to an equal
city or increased stability. Additionally, the importance number of T cells that were stimulated with IL-2 (10 U/ml; R&D
of potential contacts made between DC-SIGN and mole- Systems) and PHA (10 g/ml; Sigma, St. Louis, MO) for 2 days. For
experiments performed with HIV-luciferase-pseudotyped virus, cellscules present on the T cell remains to be determined.
were harvested 48 hr postinfection and luciferase activity was mea-These contacts may potentially increase the efficiency
sured using a luciferase reporter assay kit (for reading of fireflyof viral transfer from the DC-SIGN-expressing cell to the
luciferase; Promega, Madison, WI) or a dual luciferase reporter assay
target cell, or they may alter the intrinsic susceptibility kit (for reading of firefly and Renilla luciferase; Promega) and an
of the T cell to infection. The novel mechanism of specific Anthos Lucy1 microplate luminometer (Labtech International, Salz-
receptor-mediated HIV endocytosis described here may burg, Austria). For enhancement experiments performed with repli-
cation-competent HIV, aliquots of coculture supernatants werebe critical to our understanding of in vivo HIV transmis-
taken at the indicated time points and assayed for p24 antigen bysion and pathogenesis.
ELISA (Coulter). In experiments using concanamycin A, THP DC-
SIGN cells were pretreated with medium containing 10 nM concana-Experimental Procedures
mycin A (Sigma) for 2 hr at 37C. Cells were then incubated with
virus in medium containing drug for 2 hr at 37C and then added toCells
target cells in a large volume to dilute concanamycin A at least 10-Immature DC were generated and cultured as described previously
fold.(Geijtenbeek et al., 2000b). Mononuclear cells were purified from
buffy coats using Ficoll (Amersham Pharmacia, Piscataway, NJ)
and then adhered to plastic for 2 hr. Adherent cells were washed Protease Protection Experiments
DC-SIGN-expressing cells were incubated with pseudotyped vi-extensively and then cultured in RPMI (Life Technologies, Rockville,
MD), 2% autologous serum, penicillin (50 U/ml), streptomycin (50 ruses or gp120-FITC in medium on ice for 1 hr. Cells were then
washed extensively with serum-free medium, resuspended in se-U/ml), and stimulated with GM-CSF (800 U/ml; Immunex, Seattle,
WA) and IL-4 (500 U/ml; R&D Systems, Minneapolis, MN) for 7 days. rum-free medium, and shifted to 37C for various times. Cells were
mock treated with serum-free medium or treated with 0.05% trypsinMutant and wild-type THP DC-SIGN cells were generated by pack-
aging pMX DC-SIGN into a retrovirus pseudotyped with the VSV-G (for cells pulsed with pseudotyped virus; Life Technologies) or 0.05%
trypsin and 0.53 mM EDTA (for cells pulsed with gp120-FITC; Lifeenvelope protein (Deng et al., 1997; Emi et al., 1991). THP cells were
then infected, stained with the anti-DC-SIGN antibody 16d5 (a kind Technologies) for 5 min. Proteolysis was stopped by adding an equal
volume of medium containing 20% FCS. For gp120-FITC protectiongift of Y. van Kooyk) (Geijtenbeek et al., 2000b), and sorted for
expression of DC-SIGN. THP cells were grown in RPMI supple- experiments, cells were then stained for surface expression of DC-
SIGN using the mouse monoclonal antibody 16d5, followed by amented with 10% fetal calf serum (FCS), penicillin (50 U/ml), strepto-
mycin (50 U/ml), and L-glutamine (2 mM). secondary goat anti-mouse IgG antibody conjugated to PE (R&D
Systems). In gp120-FITC protection experiments using NH4Cl, cells
were pretreated for 1 hr at 37C in medium with 50 mM NH4ClPseudotyped Virus Production
Pseudotyped viruses were produced as described previously (Lan- and maintained in medium with drug during incubation with gp120.
Following washing, cells were resuspended in medium with NH4Cldau et al., 1991). Briefly, 293T cells were cotransfected with viral
envelope expression vectors and envelope-deleted HIV NL4-3 en- until protease treatment. For protection experiments with HIV pseu-
dotypes, cells were added to 293T targets and luciferase activitycoding the reporter firefly luciferase, Renilla luciferase, or GFP
cloned into the Nef open reading frame. Cell supernatants were was assayed 48 hr postinfection.
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Confocal Microscopy beta-chemokine receptors CCR3 and CCR5 facilitate infection by
primary HIV-1 isolates. Cell 85, 1135–1148.DC-SIGN-expressing cells were adhered to polylysine (Sigma)-
treated glass slides for 45 min in PBS at room temperature. Slides Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S., and Landau,
were then incubated with Aldrithiol-2-inactivated HIV particles (a N.R. (1997). Change in coreceptor use correlates with disease pro-
kind gift of J. Lifson) for 1 hr on ice, washed, and then stained for gression in HIV-1-infected individuals. J. Exp. Med. 185, 621–628.
bound HIV using pooled human serum from HIV-positive patients,
Cornelissen, M., Mulder-Kampinga, G., Veenstra, J., Zorgdrager, F.,followed by a donkey anti-human IgG secondary antibody conju-
Kuiken, C., Hartman, S., Dekker, J., van der Hoek, L., Sol, C., Coutinho,gated to Cy3 (Molecular Probes, Eugene, OR). Cells were washed,
R., et al. (1995). Syncytium-inducing (SI) phenotype suppression atplaced in medium containing 10 g/ml transferrin conjugated to
seroconversion after intramuscular inoculation of a non-syncytium-Alexa 633 (Molecular Probes), and shifted to 37C for the indicated
inducing/SI phenotypically mixed human immunodeficiency virustimes. After incubation, cells were washed again, fixed with 4%
population. J. Virol. 69, 1810–1818.paraformaldehyde, and permeabilized with PBS, 0.05% saponin,
Curtis, B.M., Scharnowske, S., and Watson, A.J. (1992). Sequence0.2% BSA. Cells were then stained with a mouse anti-LAMP anti-
and expression of a membrane-associated C-type lectin that exhib-body directly conjugated to FITC (BD PharMingen, San Diego, CA).
its CD4-independent binding of human immunodeficiency virus en-After a final wash, cells were imaged with a Zeiss LSM-510 laser
velope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89, 8356–scanning confocal microscope.
8360.
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M.,Soluble DC-SIGN
Di Marzio, P., Marmon, S., Sutton, R.E., Hill, C.M., et al. (1996).Soluble DC-SIGN (sDC-SIGN) was made by bacterial expression of
Identification of a major co-receptor for primary isolates of HIV-1.the extracellular domain of DC-SIGN linked to an N-terminal His tag
Nature 381, 661–666.to allow rapid purification. Protein was purified to95% purity using
a nickel-charged Hi-Trap chelating column (Amersham Pharmacia), Deng, H.K., Unutmaz, D., KewalRamani, V.N., and Littman, D.R.
followed by a Hi-Trap Q-ion exchange column (Amersham Phar- (1997). Expression cloning of new receptors used by simian and
macia), and a final Superdex 200 26/60 size exclusion column (Amer- human immunodeficiency viruses. Nature 388, 296–300.
sham Pharmacia). sDC-SIGN was incubated with luciferase-pseu-
Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Naga-
dotyped HIV at the concentrations indicated in 50 l DMEM
shima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., et
supplemented with 10% FCS for 30 min at 37C. For competition
al. (1996). HIV-1 entry into CD4 cells is mediated by the chemokine
assays, virus and sDC-SIGN were then added to 5 104 THP or THP
receptor CC-CKR-5. Nature 381, 667–673.
DC-SIGN cells in 50 l of medium and incubated for an additional 2
Emi, N., Friedmann, T., and Yee, J.K. (1991). Pseudotype formationhr at 37C. Cells were washed extensively with medium and added
of murine leukemia virus with the G protein of vesicular stomatitisto 5  104 293T-CD4-CCR5. For enhancement assays, HIV was
virus. J. Virol. 65, 1202–1207.incubated with sDC-SIGN at the indicated concentrations for 2 hr
at 37C before the addition to 5  104 activated T cells. Luciferase Fackler, O.T., and Peterlin, B.M. (2000). Endocytic entry of HIV. Curr.
activity was measured 48 hr postinfection. Biol. 10, 1005–1008.
Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A. (1996). HIV-1
Acknowledgments entry cofactor: functional cDNA cloning of a seven-transmembrane,
G protein-coupled receptor. Science 272, 872–877.
The authors are grateful to Y.R. Zou, F. Geissmann, J.M. Binley, and Fuller, S.D., Berriman, J.A., Butcher, S.J., and Gowen, B.E. (1995).
S. Bolland for helpful discussions. We would also like to thank J. Low pH induces swiveling of the glycoprotein heterodimers in the
Lifson for providing inactivated HIV virions, J. P. Moore for providing Semliki Forest virus spike complex. Cell 81, 715–725.
pooled human and monkey serum, and J. Hirst for assistance with
Geijtenbeek, T.B., Kwon, D.S., Torensma, R., van Vliet, S.J., vanFACS sorting. This work is supported by grants from the National
Duijnhoven, G.C., Middel, J., Cornelissen, I.L., Nottet, H.S., Kewal-Institutes of Health to D.R.L. N.B. is supported by a fellowship from
Ramani, V.N., Littman, D.R., et al. (2000a). DC-SIGN, a dendriticthe Cancer Research Institute. D.R.L. and W.A.H. are investigators
cell-specific HIV-1-binding protein that enhances trans-infection ofof the Howard Hughes Medical Institute.
T cells. Cell 100, 587–97.
Geijtenbeek, T.B., Torensma, R., van Vliet, S.J., van Duijnhoven,Received September 9, 2001; revised November 30, 2001.
G.C., Adema, G.J., van Kooyk, Y., and Figdor, C.G. (2000b). Identifi-
cation of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor
References that supports primary immune responses. Cell 100, 575–585.
Geisow, M.J. (1984). Fluorescein conjugates as indicators of subcel-Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E.,
lular pH. A critical evaluation. Exp. Cell Res. 150, 29–35.Murphy, P.M., and Berger, E.A. (1996). CC CKR5: a RANTES, MIP-
Granelli-Piperno, A., Finkel, V., Delgado, E., and Steinman, R.M.1alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-
(1999). Virus replication begins in dendritic cells during the transmis-tropic HIV-1. Science 272, 1955–1958.
sion of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9,Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu,
21–29.Y.J., Pulendran, B., and Palucka, K. (2000). Immunobiology of den-
Hernandez, L.D., Hoffman, L.R., Wolfsberg, T.G., and White, J.M.dritic cells. Annu. Rev. Immunol. 18, 767–811.
(1996). Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12,Bullough, P.A., Hughson, F.M., Skehel, J.J., and Wiley, D.C. (1994).
627–661.Structure of influenza haemagglutinin at the pH of membrane fusion.
Hladik, F., Lentz, G., Akridge, R.E., Peterson, G., Kelley, H., McElroy,Nature 371, 37–43.
A., and McElrath, M.J. (1999). Dendritic cell-T-cell interactions sup-Cameron, P.U., Freudenthal, P.S., Barker, J.M., Gezelter, S., Inaba,
port coreceptor-independent human immunodeficiency virus typeK., and Steinman, R.M. (1992). Dendritic cells exposed to human
1 transmission in the human genital tract. J. Virol. 73, 5833–5842.immunodeficiency virus type-1 transmit a vigorous cytopathic infec-
Hopkins, C.R. (1983). Intracellular routing of transferrin and trans-tion to CD4 T cells. Science 257, 383–387.
ferrin receptors in epidermoid carcinoma A431 cells. Cell 35,Chen, J.W., Cha, Y., Yuksel, K.U., Gracy, R.W., and August, J.T.
321–330.(1988). Isolation and sequencing of a cDNA clone encoding lyso-
Hopkins, C.R., and Trowbridge, I.S. (1983). Internalization and pro-somal membrane glycoprotein mouse LAMP-1. Sequence similarity
cessing of transferrin and the transferrin receptor in human carci-to proteins bearing onco-differentiation antigens. J. Biol. Chem. 263,
noma A431 cells. J. Cell Biol. 97, 508–521.8754–8758.
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Huang, Y., Paxton, W.A., Wolinsky, S.M., Neumann, A.U., Zhang, L.,
He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996).Wu, L., Mackay, C.R., LaRosa, G., Newman, W., et al. (1996). The
Immunity
144
The role of a mutant CCR5 allele in HIV-1 transmission and disease van Lent, N., Scherpbier, H.J., Veenstra, J., Boer, K., Coutinho, R.A.,
Miedema, F., and Schuitemaker, H. (1994). Macrophage-tropic vari-progression. Nat. Med. 2, 1240–1243.
ants initiate human immunodeficiency virus type 1 infection afterKempf, C., Jentsch, P., Barre-Sinoussi, F.B., Poirier, B., Morgen-
sexual, parenteral, and vertical transmission. J. Clin. Invest. 94,thaler, J.J., Morell, A., and Germann, D. (1991). Inactivation of human
2060–2067.immunodeficiency virus (HIV) by low pH and pepsin. J. Acquir. Im-
Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N.,mune Defic. Syndr. 4, 828–830.
Borsetti, A., Cardoso, A.A., Desjardin, E., Newman, W., et al. (1996).Landau, N.R., Page, K.A., and Littman, D.R. (1991). Pseudotyping
CD4-induced interaction of primary HIV-1 gp120 glycoproteins withwith human T-cell leukemia virus type I broadens the human immu-
the chemokine receptor CCR-5. Nature 384, 179–183.nodeficiency virus host range. J. Virol. 65, 162–169.
Yamashiro, D.J., Tycko, B., Fluss, S.R., and Maxfield, F.R. (1984).Lapham, C.K., Ouyang, J., Chandrasekhar, B., Nguyen, N.Y., Dimi-
Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgitrov, D.S., and Golding, H. (1996). Evidence for cell-surface associa-
compartment in the recycling pathway. Cell 37, 789–800.tion between fusin and the CD4-gp120 complex in human cell lines.
Science 274, 602–605.
Mandel, T.E., Phipps, R.P., Abbot, A., and Tew, J.G. (1980). The
follicular dendritic cell: long term antigen retention during immunity.
Immunol. Rev. 53, 29–59.
Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev.
Cell Dev. Biol. 12, 575–625.
Pope, M., Gezelter, S., Gallo, N., Hoffman, L., and Steinman, R.M.
(1995). Low levels of HIV-1 infection in cutaneous dendritic cells
promote extensive viral replication upon binding to memory CD4
T cells. J. Exp. Med. 182, 2045–2056.
Rowland-Jones, S.L. (1999). HIV: the deadly passenger in dendritic
cells. Curr. Biol. 9, R248–R250.
Ruigrok, R.W., Aitken, A., Calder, L.J., Martin, S.R., Skehel, J.J.,
Wharton, S.A., Weis, W., and Wiley, D.C. (1988). Studies on the
structure of the influenza virus haemagglutinin at the pH of mem-
brane fusion. J. Gen. Virol. 69, 2785–2795.
Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber,
C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C.,
et al. (1996). Resistance to HIV-1 infection in caucasian individuals
bearing mutant alleles of the CCR-5 chemokine receptor gene. Na-
ture 382, 722–725.
Schuitemaker, H., Koot, M., Kootstra, N.A., Dercksen, M.W., de
Goede, R.E., van Steenwijk, R.P., Lange, J.M., Schattenkerk, J.K.,
Miedema, F., and Tersmette, M. (1992). Biological phenotype of
human immunodeficiency virus type 1 clones at different stages of
infection: progression of disease is associated with a shift from
monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354–
1360.
Simmons, G., Reeves, J.D., Hibbitts, S., Stine, J.T., Gray, P.W.,
Proudfoot, A.E., and Clapham, P.R. (2000). Co-receptor use by HIV
and inhibition of HIV infection by chemokine receptor ligands. Immu-
nol. Rev. 177, 112–126.
Smith, B.A., Gartner, S., Liu, Y., Perelson, A.S., Stilianakis, N.I., Keele,
B.F., Kerkering, T.M., Ferreira-Gonzalez, A., Szakal, A.K., Tew, J.G.,
et al. (2001). Persistence of infectious HIV on follicular dendritic
cells. J. Immunol. 166, 690–696.
Steinman, R.M., Grenelli-Piperno, A., Tenner-Racz, K., Racz, P.,
Frankel, S., Delgado, E., Ignatius, R., and Pope, M. (1999). Dendritic
Cells: Biology and Clinical Applications (New York: Academic Press).
Tacchetti, C., Favre, A., Moresco, L., Meszaros, P., Luzzi, P., Truini,
M., Rizzo, F., Grossi, C.E., and Ciccone, E. (1997). HIV is trapped
and masked in the cytoplasm of lymph node follicular dendritic cells.
Am. J. Pathol. 150, 533–542.
Tew, J.G., Phipps, R.P., and Mandel, T.E. (1980). The maintenance
and regulation of the humoral immune response: persisting antigen
and the role of follicular antigen-binding dendritic cells as accessory
cells. Immunol. Rev. 53, 175–201.
Thery, C., and Amigorena, S. (2001). The cell biology of antigen
presentation in dendritic cells. Curr. Opin. Immunol. 13, 45–51.
Trkola, A., Dragic, T., Arthos, J., Binley, J.M., Olson, W.C., Allaway,
G.P., Cheng-Mayer, C., Robinson, J., Maddon, P.J., and Moore, J.P.
(1996). CD4-dependent, antibody-sensitive interactions between
HIV-1 and its co-receptor CCR-5. Nature 384, 184–187.
Trowbridge, I.S., Collawn, J.F., and Hopkins, C.R. (1993). Signal-
dependent membrane protein trafficking in the endocytic pathway.
Annu. Rev. Cell Biol. 9, 129–161.
van’t Wout, A.B., Kootstra, N.A., Mulder-Kampinga, G.A., Albrecht-
